Updated Data Matrix Available

Market Value | Market Volume | Epidemiology | Clinical Trials | Patent Landscape | Regulatory Approvals | COVID-19 Impact Analysis

Global Skincare Devices Market $24.9 Billion by 2027

The global market for skincare products (diagnostic and treatment devices) market to expected to attain $24.9 billion by 2027, expanding at a double-digit of CAGR of 11.2% over the forecast period, driven by rising incidence of skin disorders and availability of wide range of diagnostic and therapeutic options.

  • Other factors driving the market include higher preference for minimally or non-invasive skincare procedures, rapidly aging population, and growing medical tourism in emerging markets.
Global Skincare Devices Market

Skin and soft-tissue infections (SSTIs) are among the most common bacterial infections, posing considerable diagnostic and therapeutic challenges. Innovation in the personal care, health and beauty industry has traditionally been dominated by R&D in formulation chemistry and huge marketing budgets. 

  • Skincare devices can be used in multiple ways namely diagnostic devices that provide consumers information about their care regime, and devices that are used in combination with a chemistry to deliver therapeutic benefit as standalone therapeutic devices.
    • The trend is evidenced by a number of global companies starting programmes to evaluate integrated technology-enabled devices and diagnostics into existing chemistry based brands.

Infections of the skin and soft tissues range from mild superficial processes that can be managed in outpatients to life-threatening infections requiring hospitalization, intensive care, and combined surgical and medical support.


According to the Global Burden of Disease (GBD) project, skin diseases continue to be the 4th leading cause of nonfatal disease burden world-wide, emphasizing the role of dermatology in the ever-expanding field of global health. 

  • The burden of skin conditions was high in both high- and low-income countries, indicating that prevention of skin diseases should be prioritized.
  • SSTIs are among the most common bacterial infections, accounting for ~10% of hospital admissions for infections in the USA.
  • Skin diseases cause significant non-fatal disability worldwide, especially in resource-poor regions.
  • Greater impetus to study the burden of skin disease in low resource settings and policy efforts towards delivering high quality care are essential in improving the burden of skin diseases.
Skincare Diagnostics and Treatment Devices Market

The current front runners are undoubtedly skincare and hair-care; but oral health, sexual health, home-care and diet  products are too growing fast. 

  • The skincare devices align with consumer needs relating to time-saving, value for money, instant results and a pleasurable experience.
    • Efficacy improvements and personalization are key growth drivers of the ongoing beauty device boom, leading to functional and diagnostic skincare devices. 
      • Emerging trend are indicating more beauty treatments at home. Compared to at a spa or salon,  electrical or battery powered beauty devices are currently being used at home globally.

The global skincare devices market report provides market size estimates ($million 2017 to 2027), market share, growth trends, forecast (CAGR% 2021 to 2027).

The global market for skincare devices (diagnostic and therapeutic products) segmented by product [diagnostics devices (biopsy devices, dermatoscopes, image guidance systems), treatment devices (cryotherapy devices, electrosurgical devices, lasabrasion devices, LED therapy devices, liposuction devices, microdermabrasion devices)], by application (cellulite reduction, damage repair, disease diagnosis and treatment, hair removal, skin rejuvenation, skin tightening and body contouring), and geography.

  • Based on the skincare products, the treatment devices segment accounted for the largest share of the total skincare market, and is predicted to witness double-digit growth rate during the forecast period.
    • Among the skincare diagnostic devices segment, the dermatoscopes sub-segment dominated the market, whereas the biopsy devices sub-segment expected to grow at slightly higher rate in the coming years.
    • LED therapy devices sub-segment registered the highest revenue share of skincare treatment devices segment, whereas the lasabrasion devices (laser skin resurfacing) sub-segment anticipated to grow at a double-digit growth rate throughout the forecast period.
  • In terms of applications, the cellulite reduction segment dominated the skincare market, while the skin tightening and body contouring segment expected to grow at the fastest rate during the next few years.

The global market for skincare products consisting diagnostic and treatment devices research report is further divided by geography into North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), Latin America (Brazil, Mexico, Rest of LA), and Rest of the World.

  • Geographically, the North America followed by Europe region accounted for the largest revenue generating regions, attributed to technological advances in aesthetic products, rising baby boomer population, and growing incidence of various types of skin cancers.
    • However, the Asia Pacific region predicted to register the fastest growth rate over the forecast period, owing to large untapped population and rise in the adoption of minimally invasive procedures in the emerging markets.

The global skincare products market research report also provides the detailed market landscape and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and/or services offered, and recent trends in strategic management.

Major competitors operating in the global skincare devices market and included in this report are Alma Lasers, Inc., Bausch Health Companies, Inc, (Valeant Pharmaceuticals), Cutera, Inc., Cynosure, Inc., GE Healthcare, Human Med AG, Lumenis, Ltd., Merz, Inc., Michelson Diagnostics Ltd., Photomedex, Inc., Solta Medical International, Inc., Syneron Medical Ltd., Ulthera, Inc., and ZELTIQ Aesthetics, Inc. (Allergan plc).

  • Product
    • Diagnostic Devices
      • Biopsy Devices
      • Dermatoscopes
      • Image Guidance Systems
    • Treatment Devices
      • Cryotherapy Devices
      • Electrosurgical Devices
      • Lasabrasion Devices (Laser Skin Resurfacing)
      • LED Therapy Devices
      • Liposuction Devices
      • Microdermabrasion Devices
  • Application
    • Cellulite Reduction
    • Damage Repair
    • Disease Diagnosis and Treatment
    • Hair Removal
    • Skin Rejuvenation
    • Skin Tightening and Body Contouring
  • Geography
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Rest of the World
  • Company Profiles
    • Alma Lasers, Inc.
    • Bausch Health Companies, Inc, (Valeant Pharmaceuticals)
    • Cutera, Inc.
    • Cynosure, Inc.
    • GE Healthcare
    • Human Med AG
    • Lumenis, Ltd.
    • Merz, Inc.
    • Michelson Diagnostics Ltd.
    • Photomedex, Inc.
    • Solta Medical International, Inc.
    • Syneron Medical Ltd.
    • Ulthera, Inc.
    • ZELTIQ Aesthetics, Inc. (Allergan plc)

To request Table of Contents and Sample Pages of this report visit:

Related publications:

    Request ToC/Sample information for this market analysis

    Full Name*

    Company Email*

    Phone Number* [Please add country code]



    Secure Online Payment

    iHealthcareAnalyst, Inc.

    Contact Address

    US Office: 2109, Mckelvey Hill Drive, Maryland Heights, MO 63043, United States
    Phone: +1 (314) 463-5840
    India Office: 5, Shilpa Chambers, Opp. J. M. Road, Shivajinager, Pune 411005, India
    Phone: +91 (20) 25898524
    Email: [email protected]